Finance

Beta
Lists
WGS:NASDAQ
GeneDx Holdings Corp
$68.67
+8.07%
(+5.13) 1D
$68.40
-0.39% (-0.27)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WGS...
Open
$63.52
High
$68.95
Low
$63.50
Mkt. cap
2.04B
Avg. vol.
1.25M
Volume
0.00
52-wk high
$170.87
52-wk low
$32.21
EPS
-$2.67
Beta
1.96
Shares outstanding
29.69M
No. of employees
1K
Open
$63.52
High
$68.95
Low
$63.50
Mkt. cap
2.04B
Avg. vol.
1.25M
Volume
0.00
52-wk high
$170.87
52-wk low
$32.21
EPS
-$2.67
Beta
1.96
Shares outstanding
29.69M
No. of employees
1K
News stories
From sources across the web
About GeneDx Holdings Corp
CEO-
Employees1.3K
Founded2000
HeadquartersStamford, Connecticut, United States
SectorHealth care provider
Websitegenedx.com
Analyst ratings
Based on 8 analysts giving stock ratings to WGS in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for WGS in the last 3 months.
Highest
Current $68.67
$100.00 (+45.62%)
Average
$75.43 (+9.84%)
Lowest
$55.00 (-19.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Buy
Maintained
$63.00
-8.3%
06/23/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
06/09/2026
Tycho Peterson
Jefferies
Buy
Maintained
$100.00
+45.6%
05/27/2026
John Wilkin
Craig-Hallum
Buy
Reiterated
$85.00
+23.8%
05/05/2026
Mark Massaro
BTIG
Buy
Reiterated
$90.00
+31.1%
05/05/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
$70.00
+1.9%
05/04/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$75.00
+9.2%
05/05/2026
Brandon Couillard
Wells Fargo
Buy
Reiterated
$75.00
+9.2%
05/05/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
$55.00
-19.9%
05/05/2026
Last report
May 4, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.28 / -$0.02
-1,407.81%miss
Revenue / Est. (USD)
102.25M / 112.45M
-9.07%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
102.69M
116.74M
120.99M
102.25M
Cost of goods sold
31.79M
32.22M
36.72M
34.04M
Cost of revenue
31.79M
32.22M
36.72M
34.04M
Research and development expenses
15.08M
19.83M
24.54M
19.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46.86M
67.95M
72.56M
74.59M
Operating expense
61.94M
87.78M
97.10M
94.40M
Total operating expenses
93.73M
119.99M
133.82M
128.44M
Operating income
8.96M
-3.25M
-12.83M
-26.18M
Other non operating income
3.32M
-1.08M
-2.56M
2.33M
EBT including unusual items
10.56M
-7.39M
-18.23M
-62.42M
EBT excluding unusual items
11.46M
-4.89M
-15.91M
-24.57M
Income tax expense
-246.00K
247.00K
-564.00K
897.00K
Effective tax rate
-2.33%
-3.34%
3.09%
-1.44%
Other operating expenses
-
-
-
-
Net income
10.81M
-7.64M
-17.67M
-63.32M
Net profit margin
10.53%
-6.54%
-14.60%
-61.92%
Earnings per share
0.50
0.49
0.14
-0.28
Interest and investment income
-
-
-
-
Interest expense
-817.00K
-562.00K
-520.00K
-717.00K
Net interest expenses
-817.00K
-562.00K
-520.00K
-717.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
15.15M
3.22M
-6.85M
-19.38M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of WGS
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer